New Drug Company Fights Scarring Diseases
Two drug companies, Skye Bioscience and Redx Pharma, join forces to create Fibrx Therapeutics and gain $125 million.
People with scarring diseases face a tough fight. Their bodies create too much scar tissue. This tissue can harm organs like the lungs or liver. Now, a new company is stepping up to help.
Skye Bioscience and Redx Pharma are two drug companies. They have teamed up to form a brand new company. Its name is Fibrx Therapeutics. This new company will focus on finding drugs for these scarring diseases. It will work to stop or even reverse the harm.
This new company starts strong. It has secured $125 million in new money. This funding will help it push forward with its drug research. Fibrx Therapeutics aims to bring new treatments to patients who need them most.
This merger means more hope for patients. More money and more smart people will now work together. They will find new ways to fight serious illnesses that cause scarring.
More from Biotech
